Genomic Biomarkers to Improve Ulcerative Colitis Neoplasia Surveillance

No adequate means exist to identify the minority of ulcerative colitis (UC) patients destined to undergo neoplastic progression. Recognition of this subset would advance UC cancer surveillance by focusing the available management options onto the highest risk patients. Three different assays of geno...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bronner, Mary P., O'Sullivan, Jacintha N., Rabinovitch, Peter S., Crispin, David A., Chen, Lu, Emond, Mary J., Rubin, Cyrus E., Brentnall, Teresa A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Investigative Pathology 2008
Materias:
Regular Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2626395/
https://ncbi.nlm.nih.gov/pubmed/18988798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2008.080250
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares